Patent ID: 7888310
Filing Date: 2011-02-15
Classification: A61K,A61P,G01N,Y10S,Y10T

Abstract:
1. A method of identifying patients to be treated by dopamine agonist therapy comprising the steps of: analyzing a plasma or urine sample from said patient for concentrations of norepinephrine (NE), norepinephrine metabolites (NE metabolites), dopamine, dopamine metabolites, serotonin, serotonin metabolites, or fasting triglycerides, wherein one or more of: is/are greater than about 30% over normal level; or dopamine or dopamine metabolites are less than about 30% below normal; or fasting triglycerides are greater than about 150 mg/dl and/or said patient has blood pressure of greater than about 135/85 mm Hg.